DNA repair biomarkers XPF and phospho-MAPKAP kinase 2 correlate with clinical outcome in advanced head and neck cancer.
<h4>Background</h4>Induction chemotherapy is a common therapeutic option for patients with locoregionally-advanced head and neck cancer (HNC), but it remains unclear which patients will benefit. In this study, we searched for biomarkers predicting the response of patients with locoregion...
Guardado en:
Autores principales: | Tanguy Y Seiwert, XiaoZhe Wang, Jana Heitmann, Vivian Villegas-Bergazzi, Kam Sprott, Stephen Finn, Esther O'Regan, Allan D Farrow, Ralph R Weichselbaum, Mark W Lingen, Ezra E W Cohen, Kerstin Stenson, David T Weaver, Everett E Vokes |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8c508f0d8e494bdca4110695a9b7a55c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Acetylation of XPF by TIP60 facilitates XPF-ERCC1 complex assembly and activation
por: Jiajia Wang, et al.
Publicado: (2020) -
Mover is a homomeric phospho-protein present on synaptic vesicles.
por: Saheeb Ahmed, et al.
Publicado: (2013) -
The splicing factor XAB2 interacts with ERCC1-XPF and XPG for R-loop processing
por: Evi Goulielmaki, et al.
Publicado: (2021) -
Single sample expression-anchored mechanisms predict survival in head and neck cancer.
por: Xinan Yang, et al.
Publicado: (2012) -
DeepPhospho accelerates DIA phosphoproteome profiling through in silico library generation
por: Ronghui Lou, et al.
Publicado: (2021)